Welcome to Santa Cruz Biotechnology!

ERAL1 Antibodies

Santa Cruz Biotechnology, Inc. offers a broad range of ERAL1 antibodies. Select ERAL1 antibodies from several monoclonal and/or polyclonal ERAL1 antibodies listed below. View detailed ERAL1 antibody specifications by linking to the specific product blocks. Select appropriate ERAL1 antibodies for your research by isotype, epitope, applications and species reactivity. ERAL1 gene silencer products in siRNA, shRNA Plasmid and shRNA Lentiviral Particle formats are also available.

Introducing HOVERcruz™,

a unique system for rapid identification of ERAL1 Antibodies. Hover over product names in the table to see representative data for each product.

Live chat is now available! (click here)

Our live chat system is available to answer your product and ordering questions.

PRODUCT NAMECAT. #ISOTYPEEPITOPEAPPLICATIONSSPECIESCITATIONSRATING
ERAL1 (R-16)sc-101951rabbit IgGN/AWB, IP, ELISAhuman

ERAL1 siRNA, shRNA Plasmid and shRNA Lentiviral Particles gene silencers include:

siRNAsshRNA PlasmidsshRNA Lentiviral ParticlesCITATIONSRANKING
ERAL1 siRNA (h): sc-94130ERAL1 shRNA Plasmid (h):
sc-94130-SH
ERAL1 shRNA (h)
Lentiviral Particles: sc-94130-V
ERAL1 siRNA (m): sc-144919ERAL1 shRNA Plasmid (m):
sc-144919-SH
ERAL1 shRNA (m)
Lentiviral Particles: sc-144919-V

In E. coli, Era is a GTPase that is crucial for cell cycle progression and proper cell division, playing a key role in cellular proliferation. ERAL1 (Era G-protein-like 1), also known as ERA, ERAL1A, HERA-A, HERA-B or CEGA (conserved ERA-like GTPase), is a 437 amino acid human homolog of Era. Functioning as a probable GTP-binding protein, ERAL1 contains the same structural domains as its yeast counterpart, namely a conserved BoxA sequence, a C-terminal KH domain and an N-terminal GTP-binding domain. Due to the high level of structural similarity with Era, ERAL1 may participate in cell cycle events, including cellular proliferation and cell division. ERAL1 contains one KH type-2 domain and is expressed as two isoforms, designated HERA-A and HERA-B, which are produced due to alternative splicing events.